Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Citi
Moodys
Baxter
AstraZeneca
Farmers Insurance
Cantor Fitzgerald
McKinsey
Fish and Richardson

Generated: December 11, 2017

DrugPatentWatch Database Preview

DESOXYN Drug Profile

« Back to Dashboard

When do Desoxyn patents expire, and when can generic versions of Desoxyn launch?

Desoxyn is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in DESOXYN is methamphetamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Recordati RareDESOXYNmethamphetamine hydrochlorideTABLET, EXTENDED RELEASE;ORAL005378-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Recordati RareDESOXYNmethamphetamine hydrochlorideTABLET;ORAL005378-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Recordati RareDESOXYNmethamphetamine hydrochlorideTABLET, EXTENDED RELEASE;ORAL005378-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Recordati RareDESOXYNmethamphetamine hydrochlorideTABLET, EXTENDED RELEASE;ORAL005378-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Citi
AstraZeneca
Chinese Patent Office
Cerilliant
Cantor Fitzgerald
Chubb
Daiichi Sankyo
Johnson and Johnson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot